Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA [Yahoo! Finance]
Simulations Plus, Inc. (SLP)
Last simulations plus, inc. earnings: 4/9 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
simulations-plus.com/software/overview
Company Research
Source: Yahoo! Finance
DILIsym is a modernized Quantitative Systems Toxicology software for forecasting and analyzing drug-induced liver injury (DILI). The software is specifically engineered to evaluate the potential of DILI risk in new molecules and offer knowledge on the mechanisms that fuel DILI response at multiple levels of the drug development process. This aids pharmaceutical development teams in the understanding of compounds and outlines safe dosing strategies. Authorized employees across all FDA verticals gain continuous access to the DILIsym by renewing SLP's license for another year. The use of the software aligns with FDA's vision of safe evaluation and approval of drugs. SLP has been part of the DILI-sim Initiative for the past 14 years. DILI-sim is a public-private consortium between DILIsym Services, Inc. and numerous pharmaceutical companies to cushion the development of the DILIsym platform. The platform is also used for providing consultancy on safety-related concerns to the SLP.
Show less
Read more
Impact Snapshot
Event Time:
SLP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLP alerts
High impacting Simulations Plus, Inc. news events
Weekly update
A roundup of the hottest topics
SLP
News
- Simulations Plus' (NASDAQ:SLP) Returns On Capital Not Reflecting Well On The Business [Yahoo! Finance]Yahoo! Finance
- InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance [Yahoo! Finance]Yahoo! Finance
- Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year [Yahoo! Finance]Yahoo! Finance
- Simulations Plus stock jumps 25% amid FDA renewal, earnings report [Seeking Alpha]Seeking Alpha
- Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
SLP
Earnings
- 4/3/24 - Beat
SLP
Sec Filings
- 4/5/24 - Form 10-Q
- 4/3/24 - Form 8-K
- 4/2/24 - Form 4
- SLP's page on the SEC website